Abstract
Transdermal drug delivery can offer potential advantages over conventional oral and parenteral drug administration. However, the protective function of skin imposes a physicochemical barrier to the penetration of hydrophilic and large molecules. The skin is permeable to only small lipophilic drugs. Electroporation utilizes high-voltage electric pulses for very short duration (microsecond–millisecond) to permeabilize the skin and enable the transport of various molecules, including large and hydrophilic substances into and across the skin. The efficiency of molecular transport depends on both the electrical parameters of the pulses and the physicochemical characteristics of the permeant. The in vivo electroporation is generally well tolerated, but may sometimes cause itching, pricking, muscle contractions, and pain. These unwanted side effects could be avoided by the selection of proper electrodes and optimization of the electroporation parameters. This chapter presents the mechanism of percutaneous penetration enhancement induced by electroporation, discusses factors influencing percutaneous penetration of drug molecules, addresses effects of electroporation on the skin when used in vivo, and describes the potential use of electroporation for transdermal drug delivery.
Access provided by CONRICYT-eBooks. Download chapter PDF
Similar content being viewed by others
Keywords
1 Introduction
The administration of drugs to the skin has been practiced for centuries to treat local diseases, but it has only been used for systemic drug delivery since the 1970s with the introduction of transdermal patches (Roy et al. 1996). This route holds several key advantages over other routes of administration, including avoidance of gastric degradation and first-pass metabolism of drug molecules in addition to superior patient compliance. However, the major limitation of this route of drug administration is that the skin is permeable to only small lipophilic drugs and is highly impermeable to hydrophilic and macromolecular drugs. The poor transportation of hydrophilic or charged molecules across the skin is primarily attributed to the lipophilic nature of the stratum corneum (SC) and its low water content (Flynn 1989). The successful transdermal/topical formulation of a drug depends on the permeation rate of the drug molecule across and into the skin to achieve and retain therapeutic levels throughout the duration of use. The permeation of a drug through the SC is largely dependent on the partition coefficient of the drug molecule. Ideally, a drug must possess both aqueous and lipid solubility. If a drug is highly hydrophilic, it will not be able to transfer into the SC layer. In contrast, a highly lipophilic drug will tend to form a depot in the SC layer. As many of the drugs lack desired physicochemical properties of percutaneous absorption, percutaneous penetration enhancers are promising in the development of transdermal formulations. An ideal percutaneous penetration enhancer should promote the transport of drugs across/into the skin in a predictable way without any irreversible effects on the skin barrier properties. Several studies examined this aspect and explored various enhancement methods, including physical and chemical techniques to overcome the barrier properties of the skin (Barry 2002; McConville 2016; Prausnitz et al. 2004; Singh and Singh 1993; Sugino et al. 2009). The present chapter focuses on electroporation, an electrical method to enhance the transport of drug molecules across/into the skin by overcoming the barrier of the SC.
The use of electrical current for enhancing the percutaneous penetration of drugs, that are otherwise impermeable, was known for a long time. More than a century ago, LeDuc (1908) demonstrated the transdermal delivery of strychnine and potassium cyanide into rabbits using a low-voltage electric current, known as iontophoresis (Tyle 1986). In contrast, electroporation is a relatively new technique of percutaneous penetration enhancement which makes use of high-voltage electric current (Denet et al. 2004; Prausnitz et al. 1993a). Both iontophoresis and electroporation use electric current to enhance the percutaneous absorption of drugs and macromolecules, with the difference being that the iontophoresis acts primarily on the drug molecule, while electroporation acts on the skin structure as well as to some extent on the drug molecules. Electroporation is a physical technique which involves the application of very short duration (microsecond–millisecond) high-voltage electric pulses to reversibly enhance cell or tissue permeability for bioactive molecules such as drugs, dyes, vitamins, peptides, proteins, DNA, RNA, etc. (Chabot et al. 2015; Charoo et al. 2010; Espinos et al. 2001; Neumann et al. 2000). Electroporation may not show significant difference over the other enhancement methods for the transdermal delivery of small ions/molecules, but shows dramatically higher fluxes of macromolecules in comparison to other enhancement methods. The major advantage of this technique is that the macromolecules such as peptide and gene-based drugs could become potential candidates for transdermal delivery (Barry 2001; Dujardin and Preat 2004; McCoy et al. 2014; Medi and Singh 2003). The other potential advantages are that we can have a better control over the amount of drug delivered and kinetics of drug delivery (Potts 1993). Furthermore, electroporation is inexpensive and relatively simple to perform (Lakshmanan et al. 2014).
2 Mechanisms of Percutaneous Penetration Enhancement
Electroporation of cell membrane has been studied extensively and used since the 1970s for DNA transfection of the cells by reversibly permeabilizing the cell membranes with the application of brief electric pulses (Auer et al. 1976; Dean et al. 2003; Kinosita and Tsong 1977a; Neumann and Rosenheck 1972; Young and Dean 2015). Although the detailed molecular mechanism of electroporation is still not completely understood, the application of strong electric field pulses to cells and tissue is known to cause some type of structural rearrangement of the cell membrane. Many theoretical models have been put forward to explain the mechanisms of electroporation. However, there is a general agreement in the literature that the applied field induces some sort of metastable structural defect in the membrane, which serves as a pathway for macromolecular entry (Golzio et al. 2002; Hristova et al. 1997; Prausnitz et al. 1993a; Yarmush et al. 2014). The main idea behind using electroporation for percutaneous penetration enhancement is to perturb the barrier property of SC to enhance the transport of drugs.
The transmembrane potential induced in a cell by an external field is usually described by the following equation:
where V m is the transmembrane potential, ƒ is a function describing the electrical and geometrical properties of the cell, E is the strength of applied electric field, r is the cell radius, and θ is the polar angle with respect to the direction of the external field. Many researchers list the value of ƒ as 1.5 (Kotnik et al. 1997, 1998). Electroporation is attained when V m is greater than the threshold potential (V s ). As the bilayer cell membrane is a common feature for eukaryotic cells, the value of V s is comparable to different cell types and is reported to be 1 V (Kinosita and Tsong 1977b). However, the theoretical and experimental study conducted by Teissie and Rols (Teissie and Rols 1993) described Vs as being 200 mV. Therefore, a pulse voltage of 20–40 V (about 250–500 mV/bilayer) is sufficient to achieve short-term permeabilization of multilayer SC (~70–100 lipid bilayers) (Gallo et al. 1997; Pliquett et al. 1995). For prolonged permeabilization of the SC, a pulse voltage higher than 75 V (1 V/bilayer) is required.
2.1 Expansion of Preexisting Pathways
A schematic drawing of the SC with the possible pathways of transport during electroporation is shown in Fig. 7.1. At relatively low voltages (<30 V across the skin), the drop in skin resistance and enhanced transdermal transport can be mainly attributed to electroporation of the appendageal ducts present in the skin (Chizmadzhev et al. 1998). However, electroporation of the appendageal ducts does not show dramatic increase in the transdermal transport of molecules (Chen et al. 1998). At higher voltages (>30 V), electroporation of the lipid-corneocyte matrix leads to an additional drop in skin resistance, which allows dramatic increase of the drug transport (Chen et al. 1998; Weaver et al. 1999).
2.2 Creation of New Pathways
Application of electric pulses of high voltage to the skin results in a dramatic increase of transdermal transport associated with reversible structural changes in the skin (Prausnitz et al. 1993a) which causes permeabilization of the SC and is generally believed to occur through the formation of aqueous pathways across the lipid bilayers of the SC. Electroporation alters lipid bilayers when transient electric field leads to the formation of non-lamellar lipid phases: a pore, also called localized transport region (LTR). These new aqueous pathways are thought to be formed when the water from both sides of the membrane meets due to the electric field force (Pliquett 1999). The pore mechanism for the enhanced transdermal transport is generally accepted. In addition to electroporation, the local electric field also provides a driving force for the small ions and water-soluble molecules to traverse the skin through these newly created pathways (Vaughan and Weaver 2000).
2.3 Thermal Effects Due to Electroporation
When electrical energy passes through a resistance, it is transformed into heat. According to the first law of thermodynamics, the electrical energy released into a system will increase the energy level of the sample. Thus, the heat production due to electrical energy dissipation results in an increase in the sample temperature. However, the increases in the temperature are not drastic as the whole circuit is involved in the energy dissipation, not just the sample (Lurquin 1997). Nevertheless, caution should be observed when multiple pulses of longer duration are applied. It is hypothesized that the application of electric pulses causes temperature rise in the SC during electroporation, which might further contribute to permeation enhancement. It was estimated by computer simulation that for a peak voltage of 70 V exponential decay pulse across the SC, the temperature rise would be 19 °C (Martin et al. 2002). These temperature rises occurred within localized regions surrounding the LTRs and are called localized dissipation regions (LDRs) (Pliquett et al. 2002; Weaver et al. 1998). The morphological changes studied using time-resolved freeze-fracture electron microscopy following electroporation revealed the formation of multilamellar vesicles of 0.1–5.5 nm in diameter in the intercellular lipid bilayers of the SC (Gallo et al. 1999). These vesicles were similar to those formed when the SC is heated to 65 °C, suggesting that these changes are related to the heating effect of the electric pulses (Gallo et al. 1999). The temperature rise within SC may alter the structure and prolong the recovery of the skin barrier after electroporation (Murthy et al. 2004).
2.4 Molecular Transport Mechanisms
Diffusion, electrophoretic movement, and electroosmosis are the major mechanisms of molecular transport through temporary permeabilized skin by electroporation (Tien and Ottova 2003). While diffusion plays a major role in the permeation of small uncharged molecules (Tekle et al. 1994), electrophoretic movement is the main driving force for the transport of charged macromolecules such as DNA (Prausnitz et al. 1993a; Regnier et al. 1999). Although diffusion can occur during and after pulse application, electrophoresis is evident only during pulse application (Escobar-Chavez et al. 2009). In contrast to iontophoresis, the use of short-time electric pulse limits the contribution of electroosmosis in drug permeation by skin electroporation. The impact of diffusion and electrophoresis depends on the physicochemical properties of the drug such as geometric size, shape, and charge (Chen et al. 2006).
3 Factors Influencing Percutaneous Penetration Enhancement by Electroporation
There are several parameters influencing the extent of percutaneous penetration enhancement of drug molecules using electroporation. These include both electrical parameters associated with the pulses and physicochemical properties of the molecules to be delivered.
3.1 Electrical Parameters
3.1.1 Types of Pulses
Two different types of pulses (wave forms), square-wave (Denet and Préat 2003; Medi and Singh 2003) and exponentially decaying (Chang et al. 2000; Prausnitz et al. 1993a), are being investigated for percutaneous penetration enhancement (Fig. 7.2). Square-wave pulse electroporators generate a voltage pulse using fast switches. Basically, the power supply set to generate a given voltage is connected to a square-wave pulse generator, which closes the circuit at t = 0 and opens it at a defined time point later. Thus, the theoretical shape of the wave is as shown in Fig. 7.2a. Square-wave pulses do not rely on capacitor discharge into the circuit as in the case of exponential decay pulses. Hence, square-wave electroporation permits the use of multiple pulses of fixed voltage for a constant period of time (Golzio et al. 1998; Jordan et al. 2008). It has been reported that higher gene transfection efficiencies can be achieved when square-wave electroporation is utilized to transfer DNA into cells (Liu and Bergan 2001; Takahashi et al. 1991). However, during exponential decay wave forms (Fig. 7.2b), an initial pulse voltage is selected, and the duration of the decay depends on the capacitance setting of the electroporation system and the resistance of the skin. Therefore, the reproducibility of exponential decay pulse conditions for clinical application might be problematic, while this is not an issue with square-wave pulses (Denet et al. 2004). Nevertheless, skin electroporation using exponentially decaying pulses was shown to be more effective (Fig. 7.3). Due to its long voltage tail, exponential decaying pulses can expand or maintain the high-permeability state of the skin for a prolonged period of time to facilitate the electrophoretic mobility of drugs (Vanbever et al. 1996).
3.1.2 Pulsing Parameters
The pulsing parameters, such as pulse amplitude, pulse length, number of pulses, and the interval between each pulse, can have a dramatic effect on the transport of drugs through the skin during electroporation. Pulse amplitude is reported to be a critical parameter, which has a profound effect on the transdermal delivery of drugs (Zorec et al. 2013). Sharma et al. (2000) reported that the transport of terazosin hydrochloride through hairless rat skin was enhanced linearly with pulse amplitude using exponentially decaying pulses. In another study human parathyroid hormone (1–34), hPTH (1–34), delivery was shown to depend linearly on the pulse amplitude using square-wave pulses (Fig. 7.4) (Medi and Singh 2003). The pulse length and number of pulses also affect the extent of transdermal delivery as shown in Figs. 7.5 and 7.6, respectively. The pulsing frequency might also play an important role as the large number of pulses with a big time gap between them may not be useful, which allows the recovery of skin barrier before the application of the next pulse.
3.1.3 Electrode Design
Since the intensity and distribution of the electrical field can be significantly affected by electrode geometry and their position throughout the pulse application, the efficiency of drug transport is greatly influenced by the proper selection of electrodes and their positioning with respect to the tissue to be electroporated (Kanduser and Miklavcic 2008). For use in medicine, electrode design has to allow both efficient drug/gene transport and maximum protection of the surrounding tissue from cell damage.
The electrodes used for skin electroporation can be classified into two major groups: noninvasive electrodes and invasive electrodes. The most common noninvasive electrode consists of two parallel plate electrodes with either fixed or variable distances positioned around the injected sample. Although simple plate electrodes are often used in a clinical setting for the treatment of cutaneous and subcutaneous metastases, they can cause superficial skin burning and stimulation of underlying muscles and nerves (Denet et al. 2004). The use of a meander electrode can protect the underlying tissue from undesirable side effects since its electric field is mostly localized within the superficial skin layers (Denet et al. 2004). Heller et al. (2007) have designed a special type of plate electrode (4PE) consisting of four plates to deliver electric pulses in two different orientations perpendicular to each other. This electrode design provides easier and more reproducible cutaneous plasmid delivery than commercially available simple plate electrodes. Other commonly used noninvasive electrode types are contact wires (Heller et al. 2001; Mazères et al. 2009; Pedron-Mazoyer et al. 2007), flat patch electrode (Babiuk et al. 2003; Heller et al. 2010; Zhang et al. 2002), and tweezers electrode. In the case of contact wire electrodes, the sample is injected between the two wires, while the flat patch electrode is placed directly on the injected sample.
The invasive electrodes comprise of various needle configurations, either in circular or pair-wise array. They are generally used for the treatment of tumors or vaccinations. Invasive electrodes are inserted near the periphery of the injection site to avoid any leakage of the sample. Maruyama et al. (2001) made a special type of electrode design where the needles were inserted into the skin parallel to the body surface, rather than conventional vertically directed electrodes. In another study, Daugimont et al. (2010) used hollow conductive microneedle arrays for the intradermal delivery of drugs and DNA. This microneedle array played a dual role in allowing needle-free intradermal injection of the sample as well as for electric pulse application in the superficial skin layers.
Since most of the skin permeation studies by electroporation have been executed in rodents, noninvasive electrodes have been used frequently. However, several studies conducted in large animals, such as pigs which have relatively thicker skin, showed the superiority of needle electrodes over conventional plate electrodes (Drabick et al. 2001). Therefore, the selection of the most suitable electrodes and their design depends upon both the purpose of electroporation as well as the characteristics of the treated cells.
3.2 Physicochemical Factors
3.2.1 Molecular Size and Charge of the Permeant
The size and charge of the drug molecule play an important role in percutaneous absorption. Figure 7.7 shows the effect of molecular weight (MW) of the permeant on the transdermal transport using electroporation, i.e., an increase of MW causes a decrease of the transport. Since the electrophoretic movement is the primary transport mechanism for charged macromolecules through the skin by electroporation, both the pKa of the permeant and the pH of the delivery formulation play a critical role in the overall absorption process. The general rule is that the higher the charge of the permeant, the greater the absorption potential (Denet et al. 2004). Electroporation has shown a 5–10,000-fold increase in the flux of calcein (Prausnitz et al. 1993a), luteinizing hormone-releasing hormone (LHRH) (Bommannan et al. 1994), heparin (Prausnitz et al. 1995), oligonucleotides (Regnier et al. 1998), fluorescein isothiocyanate (FITC)-labeled dextran (Lombry et al. 2000), insulin (Sen et al. 2002a), and hPTH (1–34) (Medi and Singh 2003). These studies suggest that electroporation can be useful for the transdermal delivery of macromolecules that could not be transported using other enhancement methods.
3.2.2 pH of the Formulation
The pH of the formulation is also an important factor that can influence the barrier properties of the skin in addition to its influence on the ionic state of the drug. Enhanced percutaneous penetration of water without electroporation was reported at pH lower than 4 and higher than 10 due to the extraction of the insoluble fraction of keratin (Matoltsy et al. 1968). The electrical impedance of the skin was also found to be decreased at a pH lower than 3 and higher than 9 (Allenby et al. 1969). Murthy et al. (2003) showed the pH dependence of the electroporation-enhanced transport using glucose and FITC-labeled dextran (FD). They reported that the transport of glucose and FD across porcine epidermis was increased by three-fold when the formulation pH was increased from pH 5 to 7.5, which might be due to the prolonged postpulse permeability state of the skin.
3.2.3 Effect of Electrolytes
The presence of monovalent electrolytes such as NaF, NaCl, NaBr, and NaI (Fig. 7.8) and divalent electrolytes such as MgCl2 and CaCl2 (Fig. 7.9) was shown to have a synergistic effect on the electroporation-enhanced transport of calcein across the hairless rat skin (Tokudome and Sugibayashi 2003). The presence of CaCl2 was shown to prolong the postpulse recovery of the skin, which might be the reason for the enhanced transport in comparison to electroporation alone (Tokudome and Sugibayashi 2004). Simultaneous application of these electrolytes and electroporation caused 10–83-fold enhancement in the skin permeation of calcein compared to electroporation alone.
3.2.4 Effect of Temperature
It is well known that temperature affects the permeability of the diffusing drug molecules through the skin (Oh et al. 1993; Peck et al. 1995). It has been shown that an increase in temperature above 40 °C results in enhanced transport of molecules with electroporation (Fig. 7.10), which is likely due to the delayed recovery of the skin following electroporation (Murthy et al. 2004).
4 Effects of Electroporation on Skin
In order to be useful clinically, the permeabilization of SC should be reversible as it is the primary barrier between the body and the environment besides playing a critical role in regulating the homeostatic reactions. Unlike electroporation of simple lipid bilayers, which anneal immediately after ceasing the pulses, the complex lipid matrix of the SC has a slower return to normal permeability state (Riviere and Heit 1997). Although not completely understood, application of strong electric pulses to cells and tissues is known to cause some type of structural rearrangement of the cell membrane due to the combined electrical and thermal effects (Pliquett et al. 2002; Weaver 1995). In most of the cases, the overall changes to the skin following electroporation are mild and reversible.
Since the SC layer has much higher electrical resistance than underlying tissues, the applied electric field to the skin will initially concentrate in the SC and could provide efficient protection from adverse effects to the underlying viable tissues. However, upon the application of a high-voltage electric pulse, SC’s resistance drops dramatically to permit the greater extent of electric field into the deeper tissues, causing direct excitation of the underlying nerves and muscles (Prausnitz 1996). An increase in pulse voltage, duration, and rate is likely to intensify the sensation of itching, pricking, tingling, muscle contractions, and pain (Denet et al. 2004). These unwanted side effects could be avoided by the use of closely spaced microelectrodes that confine the electric field to SC layer (Pliquett and Weaver 2007). The present section delineates the studies carried out so far to address the safety issues using electroporation.
4.1 Biophysical Changes
The lipid structure of SC is known to undergo several structural rearrangements at elevated temperatures during electroporation. Although these temperatures may slightly differ for various animal species, the SC experiences roughly four endothermic phase transitions over a temperature range of 40–130 °C (Becker 2012). The phase transition that occurs within the temperature range of 60–70 °C greatly destabilizes the SC’s lipid barrier function and is primarily attributed to the disordering of the lamellar lipid phase (Cornwell et al. 1996). Biophysical methods allow investigators to study the changes of SC lipids and proteins in addition to the SC water content. Different methods including Fourier transform infrared spectroscopy (FTIR), differential thermal analysis (DTA), differential scanning calorimetry (DSC), and X-ray diffraction have been used to investigate these changes following electroporation treatment. Attenuated total reflectance (ATR)-FTIR studies show an increase in the water content of SC (Jadoul et al. 1999), which was also confirmed by thermogravimetric studies (Jadoul et al. 1998b). A dramatic perturbation in the lamellar ordering of the intercellular lipid has been reported after high-voltage pulsing using differential thermal analysis and freeze-fracture electron microscopy (Jadoul et al. 1998b). Polarized light thermal microscopy of extracted lipids from the SC shows an indication of overall lipid structure fluidization around 60 °C (Silva et al. 2006). Small-angle X-ray scattering studies carried out about 5 min after electroporation pulsing provided further evidence for a general perturbation of interlamellar and intralamellar lipid packing order (Jadoul et al. 1997).
4.2 Histological Changes
Electroporation-induced skin damage is often assessed histologically after staining with hematoxylin and eosin (Heller et al. 2008). Histological examination of the skin after electroporation showed intraepidermal edema, focal vacuolization, and degeneration of the epidermal layer (Guo et al. 2011; Riviere et al. 1995). An increased detachment of SC cell layers and an amorphous epidermis (Fig. 7.11) were reported with an increase in electroporation pulse voltage (Jadoul et al. 1998b; Medi and Singh 2003). Freeze-fracture electron microscopic studies revealed a severe distortion of the lamellar structure of the SC lipids (Jadoul et al. 1998b). Another study using time-resolved freeze-fracture electron microscopy revealed the formation of multilamellar vesicles of 0.1–5.5 nm in diameter in the SC that could be related to the heating effect of electroporation (Gallo et al. 1999).
4.3 Macroscopic Barrier and Skin Irritation
The barrier property of the skin is critical to prevent the entry of exogenous toxic chemicals into the body and also to avoid the loss of internal body components, particularly water (Roberts and Walters 1998). The effect of electroporation on the macroscopic barrier property of the skin was studied by measuring transepidermal water loss (TEWL) following electroporation in vivo in rats and rabbits (Dujardin et al. 2002; Medi and Singh 2006; Wang et al. 2007). The studies reported a reversible increase in TEWL following electroporation. It is shown to cause mild, transient erythema and edema in New Zealand white rabbits (Medi and Singh 2006). Skin irritation was measured at different time points following the visual scoring method of Draize et al. (1944). It is suggested that the use of iontophoresis followed by electroporation pulses might reduce the skin irritation (Prausnitz et al. 1993b; Vanbever et al. 1998a). This may be due to the creation of new pathways with electroporation, which results in more even distribution of the iontophoretic current (Singh and Maibach 2002). A recent study using a surface electroporation device demonstrated the effect of pulse voltage on the dermal integrity of guinea pig skin (Broderick et al. 2012). At the 48 h time point, skin sites treated with 200, 100, and 50 V electric pulses showed signs of redness and swelling. In addition, 200 and 100 V electric pulse treatments also showed signs of inflammation and scabbing, while the skin site treated with 10 V pulses did not show visible signs of tissue damage. On the contrary, electroporation of the guinea pig skin using a noninvasive multielectrode array (250 V/cm, 150 ms) demonstrated no sign of severe skin damage such as burning, ulceration, or scar formation (Guo et al. 2011). Only skin redness and prints of the electrodes were observed after electroporation and disappeared by day 5. Some transient hair loss was evident in the site of electroporation, but it grew back within 7 days of treatment. Thus, the selection of proper voltage parameters and electrodes is important to carry out safe and effective electroporation.
5 Potential Applications
Electroporation is an attractive physical technique, because it offers a simple, effective means of facilitating the permeation of a wide range of exogenous molecules across the skin by transiently disrupting the cell membrane. Moreover, for in vivo application, the area of tissue affected by electroporation can be effectively controlled or confined by the appropriate localization of applied electric field (Esser et al. 2009; Pliquett et al. 2004). The encouraging results of in vitro electroporation studies persuade researchers to investigate the potential of electroporation-based medical therapies. The current in vivo application of electroporation encompasses drug delivery (Tokumoto et al. 2006; Wong et al. 2006), gene delivery (including DNA vaccination) (Luckay et al. 2007; Medi et al. 2005; Wells et al. 2000), or electroporation alone (without any therapeutically active molecules) for tissue ablation (Al-Sakere et al. 2007). A number of studies have demonstrated that electroporation could be used to enhance the delivery of impermeant anticancer drugs to the solid tumor tissue (Gothelf et al. 2003; Mir and Orlowski 1999). More interestingly, recent studies have reported that the use of very short duration and higher-voltage electric pulses can irreversibly destroy the target cells within a limited area while leaving adjacent cells unaffected (Lee et al. 2010). This provides a new opportunity for the treatment of cancer, cardiovascular diseases, and other ailments that necessitate removal of tissue. This section emphasizes the use of electroporation for transdermal drug and gene delivery.
5.1 Transdermal or Topical Drug Delivery
Since the demonstration of the electroporation for enhanced transdermal delivery (Prausnitz et al. 1993a), numerous studies reported the delivery of several molecules. It can improve transdermal/topical delivery of drugs ranging from small molecules to macromolecules such as peptides and nucleic acids (oligonucleotides and genes). Enhanced transdermal delivery of macromolecules of at least up to 40 kDa was shown to be feasible with electroporation. Table 7.1 provides a summary of the percutaneous penetration enhancement of different drugs using electroporation.
Furthermore, skin electroporation in combination with other physical and chemical percutaneous penetration enhancers has been explored for transdermal delivery. The aim of combining chemical enhancers and electroporation is either to enlarge the pathways created by electroporation or to prolong the reversal of these pathways but not to disrupt lipids (Denet et al. 2004). Traditional chemical penetration enhancers (e.g., dimethyl sulfoxide, azone) may not be useful for this purpose (Vanbever et al. 1997). Polysaccharides such as heparin (Weaver et al. 1997), dextran (Vanbever et al. 1997), and anionic phospholipids (Sen et al. 2002b) were found to enhance transdermal delivery by electroporation. The application of ultrasound along with electroporation is not expected to have a dramatic effect as both of these techniques have similar mechanisms of action (Denet et al. 2004). However, the application of iontophoresis in combination with electroporation is anticipated to increase the transdermal transport synergistically due to the different mechanisms of action of these methods. For more details on the combined effects of electroporation and other methods, look at Chaps. 26, 27, 28, 29, 30, and 31 in this volume.
5.2 Gene Delivery
The skin is an attractive target for gene transfer due to its large size and easy accessibility (Khavari 1997). Gene transfer to the skin can be potentially useful for the treatment of local skin disorders and also for systemic disorders as it can produce and release polypeptides into the systemic circulation (Cao et al. 2000, 2002; Spirito et al. 2001). The skin is an ideal site for the genetic immunizations using plasmid DNA-based vaccines (Babiuk et al. 2002, 2003; Choi and Maibach 2003; Drabick et al. 2001; Hirao et al. 2008; Hooper et al. 2007; Roos et al. 2006). It contains a large number of professional antigen-presenting cells, such as Langerhans cells and dendritic cells, as well as permits the visual monitoring of the vaccinated area (Tobin 2006). Skin electroporation also allows the topical application of local anesthetics and use of short electrode needles, thereby greatly enhancing the tolerability of the vaccination in comparison to intramuscular DNA vaccine delivery (Roos et al. 2009). This opens up a whole new area of application for the skin-targeted delivery of gene-based therapeutics. For more detail on the gene delivery using electroporation look at Chap. 29 in this volume.
6 Conclusions and Future Prospects
Percutaneous penetration enhancement using electroporation offers a better way to enhance the transdermal drug delivery both in vitro and in vivo. Electroporation could be applied as a noninvasive delivery technique for fast, efficient, and pulsatile delivery of a wide spectrum of therapeutic molecules such as small ionized drugs, macromolecules, and nucleic acids to the skin, liver, tumor, and other tissues. Recently, electroporation has been successfully used in clinical practice in cancer electrochemotherapy and gene electrotransfer for DNA vaccines and gene therapies. Irreversible electroporation has emerged as a new surgical technique for tissue ablation. Various types of electrodes have been designed to enhance the efficacy and safety of electroporation. Generalization of the transport using electroporation cannot be done for all the drugs and biologically active molecules using models. Each individual drug needs to be studied separately, because the exact parameters required for electroporation depend on both the physicochemical properties of the drug and the cell and tissue types to be electroporated. Therefore, electroporation can be effectively used for different purposes in medicine and biotechnology if proper electrical parameters are chosen based on the condition being treated and the characteristics of the molecules being delivered. In addition to this, the design of safe and noninvasive electrodes and the development of miniaturized versions of the electroporator, probably operating on a battery, are needed for advancing this technique for routine use.
References
Allenby AC, Fletcher J, Schock C, Tees TFS (1969) The effect of heat, pH and organic solvents on the electrical impedance and permeability of excised human skin. Br J Dermatol 81(Suppl 4):31–39
Al-Sakere B, Andre F, Bernat C, Connault E, Opolon P, Davalos RV et al (2007) Tumor ablation with irreversible electroporation. PLoS One 2(11):e1135
Auer D, Brandner G, Bodemer W (1976) Dielectric breakdown of the red blood cell membrane and uptake of SV 40 DNA and mammalian cell RNA. Naturwissenschaften 63:391
Babiuk S, Baca-Estrada ME, Foldvari M, Storms M, Rabussay D, Widera G et al (2002) Electroporation improves the efficacy of DNA vaccines in large animals. Vaccine 20:3399–3408
Babiuk S, Baca-Estrada ME, Foldvari M, Baizer L, Stout R, Storms M et al (2003) Needle-free topical electroporation improves gene expression from plasmids administered in porcine skin. Mol Ther 8:992–998
Barry BW (2001) Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 14:101–114
Barry BW (2002) Drug delivery routes in skin: a novel approach. Adv Drug Deliv Rev 54(Suppl 1):S31–S40
Becker S (2012) Transport modeling of skin electroporation and the thermal behavior of the stratum corneum. Int J Therm Sci 54:48–61
Bommannan DB, Tamada J, Leung L, Potts RO (1994) Effect of electroporation on transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH) in vitro. Pharm Res 11:1809–1814
Bose S, Ravis WR, Lin YJ, Zhang L, Hofmann GA, Banga AK (2001) Electrically-assisted transdermal delivery of buprenorphine. J Control Release 73:197–203
Broderick KE, Chan A, Lin F, Shen X, Kichaev G, Khan AS et al (2012) Optimized in vivo transfer of small interfering RNA targeting dermal tissue using in vivo surface electroporation. Mol Ther Nucleic Acids 1:e11
Cao T, Wang XJ, Roop DR (2000) Regulated cutaneous gene delivery: the skin as a bioreactor. Hum Gene Ther 11:2297–2300
Cao T, Tsai SY, O’Malley BW, Wang XJ, Roop DR (2002) The epidermis as a bioreactor: topically regulated cutaneous delivery into the circulation. Hum Gene Ther 13:1075–1080
Chabot S, Teissié J, Golzio M (2015) Targeted electro-delivery of oligonucleotides for RNA interference: siRNA and antimiR. Adv Drug Deliv Rev 81:161–168
Chang SL, Hofmann GA, Zhang L, Deftos LJ, Banga AK (2000) The effect of electroporation on iontophoretic transdermal delivery of calcium regulating hormones. J Control Release 66:127–133
Charoo NA, Rahman Z, Repka MA, Murthy SN (2010) Electroporation: an avenue for transdermal drug delivery. Curr Drug Deliv 7(2):125–136
Chen T, Segall EM, Langer R, Weaver JC (1998) Skin electroporation: rapid measurements of the transdermal voltage and flux of four fluorescent molecules show a transition to large fluxes near 50 V. J Pharm Sci 87:1368–1374
Chen C, Smye SW, Robinson MP, Evans JA (2006) Membrane electroporation theories: a review. Med Biol Eng Comput 44:5–14
Chizmadzhev YA, Indenbom AV, Kuzmin PI, Galichenko SV, Weaver JC, Potts RO (1998) Electrical properties of skin at moderate voltages: contribution of appendageal macropores. Biophys J 74:843–856
Choi MJ, Maibach HI (2003) Topical vaccination of DNA antigens: topical delivery of DNA antigens. Skin Pharmacol Appl Skin Physiol 16:271–282
Cornwell PA, Barry BW, Bouwstra JA, Gooris GS (1996) Modes of action of terpene penetration enhancers in human skin; differential scanning calorimetry, small angle diffraction and enhancer uptake studies. Int J Pharm 127:9–26
Daugimont L, Baron N, Vandermeulen G, Pavselj N, Miklavcic D, Jullien MC et al (2010) Hollow microneedle arrays for intradermal drug delivery and DNA electroporation. J Membr Biol 236:117–125
Dean DA, Machado-Aranda D, Blair-Parks K, Yeldandi AV, Young JL (2003) Electroporation as a method for high-level nonviral gene transfer to the lung. Gene Ther 10(18):1608–1615
Denet AR, Préat V (2003) Transdermal delivery of timolol by electroporation through human skin. J Control Release 88:253–262
Denet AR, Ucakar B, Préat V (2003) Transdermal delivery of timolol and atenolol using electroporation and iontophoresis in combination: a mechanistic approach. Pharm Res 20:1946–1951
Denet AR, Vanbever R, Préat V (2004) Skin electroporation for transdermal and topical delivery. Adv Drug Deliv Rev 56:659–674
Drabick JJ, Glasspool-Malone J, King A, Malone RW (2001) Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization. Mol Ther 3:249–255
Draize JH, Woodward G, Cavlery HO (1944) Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 82:377–390
Dujardin N, Staes E, Kalia Y, Clarys P, Guy R, Préat V (2002) In vivo assessment of skin electroporation using square wave pulses. J Control Release 79:219–227
Dujardin N, Preat V (2004) Delivery of DNA to skin by electroporation. Methods Mol Biol 245:215–226
Escobar-Chavez JJ, Bonilla-Martinez D, Villegas-Gonzalez MA, Revilla-Vázquez AL (2009) Electroporation as an efficient physical enhancer for skin drug delivery. J Clin Pharmacol 49:1262–1283
Espinos E, Liu JH, Bader CR, Bernheim L (2001) Efficient nonviral DNA-mediated gene transfer to human primary myoblasts using electroporation. Neuromuscul Disord 11:341–349
Esser AT, Smith KC, Gowrishankar TR, Weaver JC (2009) Towards solid tumor treatment by nanosecond pulsed electric fields. Technol Cancer Res Treat 8:289–306
Fang JY, Hung CF, Fang YP, Chan TF (2004) Transdermal iontophoresis of 5-fluorouracil combined with electroporation and laser treatment. Int J Pharm 270:241–249
Flynn GL (1989) Mechanism of percutaneous absorption from physicochemical evidence. In: Bronaugh RL, Maibach HI (eds) Percutaneous absorption, mechanisms-methodology-drug delivery. Marcel Dekker, New York, pp 27–51
Gallo SA, Oseroff AR, Johnson PG, Hui SW (1997) Characterization of electric-pulse-induced permeabilization of porcine skin using surface electrodes. Biophys J 72:2805–2811
Gallo SA, Sen A, Hensen ML, Hui SW (1999) Time-dependent ultrastructural changes to porcine stratum corneum following an electric pulse. Biophys J 76:2824–2832
Golzio M, Mora MP, Raynaud C, Delteil C, Teissie J, Rols MP (1998) Control by osmotic pressure of voltage induced permeabilization and gene transfer in mammalian cells. Biophys J 74:3015–3022
Golzio M, Teissie J, Rols MP (2002) Direct visualization at the single-cell level of electrically mediated gene delivery. Proc Natl Acad Sci U S A 99:1292–1297
Gothelf A, Mir LM, Gehl J (2003) Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev 29:371–387
Guo S, Donate A, Basu G, Lundberg C, Heller L, Heller R (2011) Electro-gene transfer to skin using a noninvasive multielectrode array. J Control Release 151:256–262
Heller R, Schultz J, Lucas ML, Jaroszeski MJ, Heller LC, Gilbert RA et al (2001) Intradermal delivery of interleukin-12 plasmid DNA by in vivo electroporation. DNA Cell Biol 20:21–26
Heller LC, Jaroszeski MJ, Coppola D, McCray AN, Hickey J, Heller R (2007) Optimization of cutaneous electrically mediated plasmid DNA delivery using novel electrode. Gene Ther 14:275–280
Heller LC, Jaroszeski MJ, Coppola D, Heller R (2008) Comparison of electrically mediated and liposome-complexed plasmid DNA delivery to the skin. Genet Vaccines Ther 6:16
Heller R, Cruz Y, Heller LC, Gilbert RA, Jaroszeski MJ (2010) Electrically mediated delivery of plasmid DNA to the skin using a multi electrode array. Hum Gene Ther 21:357–362
Hirao LA, Wu L, Khan AS, Satishchandran A, Draghia-Akli R, Weiner DB (2008) Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques. Vaccine 26:440–448
Hooper JW, Golden JW, Ferro AM, King AD (2007) Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge. Vaccine 25:1814–1823
Hristova NI, Tsoneva I, Neumann E (1997) Sphingosine-mediated electroporative DNA transfer through lipid bilayers. FEBS Lett 415:81–86
Hu Q, Liang W, Bao J, Ping Q (2000) Enhanced transdermal delivery of tetracaine by electroporation. Int J Pharm 202:121–124
Jadoul A, Regnier V, Doucet J, Durand D, Préat V (1997) X-ray scattering analysis of human stratum corneum treated by high voltage pulses. Pharm Res 14:1275–1277
Jadoul A, Lecouturier N, Mesens J, Caers W, Préat V (1998a) Transdermal alniditan delivery by skin electroporation. J Control Release 54:265–272
Jadoul A, Tanojo H, Préat V, Bouwstra JA, Spies F, Boddé HE (1998b) Electroperturbation of human stratum corneum fine structure by high voltage pulses: a freeze-fracture electron microscopy and differential thermal analysis study. J Investig Dermatol Symp Proc 3:153–158
Jadoul A, Bouwstra J, Preat V (1999) Effects of iontophoresis and electroporation on the stratum corneum. Review of the biophysical studies. Adv Drug Deliv Rev 35:89–105
Jordan ET, Collins M, Terefe J, Ugozzoli L, Rubio T (2008) Optimizing electroporation conditions in primary and other difficult-to-transfect cells. J Biomol Tech 19:328–334
Kanduser M, Miklavcic D (2008) Electroporation in biological cell and tissue: an overview. In: Vorobiev E, Lebovka N (eds) Electrotechnologies for extraction from food plants and biomaterials. Springer, New York, pp 1–37
Kang TH, Monie A, Wu LS, Pang X, Hung CF, Wu TC (2011) Enhancement of protein vaccine potency by in vivo electroporation mediated intramuscular injection. Vaccine 29:1082–1089
Khavari PA (1997) Therapeutic gene delivery to the skin. Mol Med Today 3:533–538
Kinosita K Jr, Tsong TY (1977a) Formation and resealing of pores of controlled sizes in human erythrocyte membrane. Nature 268:438–441
Kinosita K Jr, Tsong TY (1977b) Voltage-induced pore formation and hemolysis of human erythrocytes. Biochim Biophys Acta 471:227–242
Kotnik T, Bobanovic F, Miklavcic D (1997) Sensitivity of transmembrane voltage induced by applied electric fields–a theoretical analysis. Bioelectrochem Bioenerg 43:285–291
Kotnik T, Miklavcic D, Slivnik T (1998) Time course of transmembrane voltage induced by time-varying electric fields–a method for theoretical analysis and its application. Bioelectrochem Bioenerg 45:3–16
Lakshmanan S, Gupta GK, Avci P, Chandran R, Sadasivam M, Jorge AE et al (2014) Physical energy for drug delivery; poration, concentration and activation. Adv Drug Deliv Rev 71:98–114
LeDuc S (1908) Electric ions and their use in medicine. Rebman, London
Lee EW, Thai S, Kee ST (2010) Irreversible electroporation: a novel image-guided cancer therapy. Gut Liver 4(Suppl 1):S99–S104
Liu Y, Bergan R (2001) Improved intracellular delivery of oligonucleotides by square wave electroporation. Antisense Nucleic Acid Drug Dev 11:7–14
Lombry C, Dujardin N, Préat V (2000) Transdermal delivery of macromolecules using skin electroporation. Pharm Res 17:32–37
Luckay A, Sidhu MK, Kjeken R, Megati S, Chong SY, Roopchand V et al (2007) Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques. J Virol 81:5257–5269
Lurquin PF (1997) Gene transfer by electroporation. Mol Biotechnol 7:5–35
Martin GT, Pliquett UF, Weaver JC (2002) Theoretical analysis of localized heating in human skin subjected to high voltage pulses. Bioelectrochemistry 57:55–64
Maruyama H, Ataka K, Higuchi N, Sakamoto F, Gejyo F, Miyazaki J (2001) Skin-targeted gene transfer using in vivo electroporation. Gene Ther 8:1808–1812
Matoltsy AG, Downes AM, Sweeney TM (1968) Studies of the epidermal water barrier. II. Investigation of the chemical nature of the water barrier. J Invest Dermatol 50:19–26
Mazères S, Sel D, Golzio M, Pucihar G, Tamzali Y, Miklavcic D et al (2009) Non invasive contact electrodes for in vivo localized cutaneous electropulsation and associated drug and nucleic acid delivery. J Control Release 134:125–131
McConville J (2016) Special focus issue: transdermal, topical and folicular drug delivery systems. Drug Dev Ind Pharm 42(6):845
McCoy JR, Mendoza JM, Spik KW, Badger C, Gomez AF, Schmaljohn CS et al (2014) A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin. Hum Vaccin Immunother 10(10):3039–3047
Medi BM, Singh J (2003) Electronically facilitated transdermal delivery of human parathyroid hormone (1–34). Int J Pharm 263:25–33
Medi BM, Hoselton S, Marepalli R, Singh J (2005) Skin targeted DNA vaccine delivery using electroporation in rabbits. I: efficacy. Int J Pharm 294:53–63
Medi BM, Singh J (2006) Skin targeted DNA vaccine delivery using electroporation in rabbits II. Safety. Int J Pharm 308:61–68
Mir LM, Orlowski S (1999) Mechanisms of electrochemotherapy. Adv Drug Deliv Rev 35:107–118
Murthy SN, Sen A, Zhao YL, Hui SW (2003) pH influences the postpulse permeability state of skin after electroporation. J Control Release 93:49–57
Murthy SN, Sen A, Zhao YL, Hui SW (2004) Temperature influences the postelectroporation permeability state of the skin. J Pharm Sci 93:908–915
Neumann E, Rosenheck K (1972) Permeability changes induced by electric impulses in vesicular membranes. J Membr Biol 10:279–290
Neumann E, Kakorin S, Toensing K (2000) Principles of membrane electroporation and transport of macromolecules. In: Jaroszeski MJ, Heller R, Gilbert R (eds) Electrochemotherapy, electrogenetherapy and transdermal drug delivery. Humana Press, Totowa, pp 1–35
Oh SY, Leung L, Bommannan D, Guy RH, Potts RO (1993) Effect of current, ionic strength and temperature on the electrical properties of skin. J Control Release 27:115–125
Peck KD, Ghanem AH, Higuchi WI (1995) The effect of temperature upon the permeation of polar and ionic solutes through human epidermal membrane. J Pharm Sci 84:975–982
Pedron-Mazoyer S, Plouet J, Hellaudais L, Teissie J, Golzio M (2007) New anti angiogenesis developments through electroimmunization: optimization by in vivo optical imaging of intradermal electro gene transfer. Biochim Biophys Acta 1770:137–142
Pliquett U, Langer R, Weaver JC (1995) Changes in the passive electrical properties of human stratum corneum due to electroporation. Biochim Biophys Acta 1239:111–121
Pliquett U (1999) Mechanistic studies of molecular transdermal transport due to skin electroporation. Adv Drug Deliv Rev 35:41–60
Pliquett UF, Martin GT, Weaver JC (2002) Kinetics of the temperature rise within human stratum corneum during electroporation and pulsed high-voltage iontophoresis. Bioelectrochemistry 57:65–72
Pliquett U, Elez R, Piiper A, Neumann E (2004) Electroporation of subcutaneous mouse tumors by rectangular and trapezium high voltage pulses. Bioelectrochemistry 62:83–93
Pliquett U, Weaver JC (2007) Feasibility of an electrode-reservoir device for transdermal drug delivery by noninvasive skin electroporation. IEEE Trans Biomed Eng 54:536–538
Potts RO (1993) Transdermal peptide delivery using electroporation. In: Proceedings of the third TDS technology symposium: polymers and peptides in transdermal delivery. Nichon Toshi Center, Tokyo, pp 47–67
Prausnitz MR, Bose VG, Langer R, Weaver JC (1993a) Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci U S A 90:10504–10508
Prausnitz MR, Seddick DS, Kon AA, Bose VG, Frankenburg S, Klaus SN et al (1993b) Methods for in vivo tissue electroporation using surface electrodes. Drug Deliv 1:125–131
Prausnitz MR, Edelman ER, Gimm JA, Langer R, Weaver JC (1995) Transdermal delivery of heparin by skin electroporation. Biotechnol (NY) 13:1205–1209
Prausnitz MR (1996) The effects of electric current applied to skin: a review for transdermal drug delivery. Adv Drug Deliv Rev 18:395–425
Prausnitz MR, Mitragotri S, Langer R (2004) Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov 3:115–124
Regnier V, Le Doan T, Préat V (1998) Parameters controlling topical delivery of oligonucleotides by electroporation. J Drug Target 5:275–289
Regnier V, De Morre N, Jadoul A, Preat V (1999) Mechanisms of a phosphorothioate oligonucleotide delivery by skin electroporation. Int J Pharm 184:147–156
Riviere JE, Monteiro-Riviere NA, Rogers RA, Bommannan D, Tamada JA, Potts RO (1995) Pulsatile transdermal delivery of LHRH using electroporation: drug delivery and skin toxicology. J Control Release 36:229–233
Riviere JE, Heit MC (1997) Electrically-assisted transdermal drug delivery. Pharm Res 14:687–697
Roberts MS, Walters KA (1998) The relationship between structure and barrier function of skin. In: Roberts MS, Walters KA (eds) Dermal absorption and toxicity assessment. Marcel Dekker, New York, pp 1–42
Roos AK, Moreno S, Leder C, Pavlenko M, King A, Pisa P (2006) Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation. Mol Ther 13:320–327
Roos AK, Eriksson F, Timmons JA, Gerhardt J, Nyman U, Gudmundsdotter L et al (2009) Skin electroporation: effects on transgene expression. DNA persistence and local tissue environment. PLoS One 4(9):e7226
Roy SD, Gutierrez M, Flynn GL, Cleary GW (1996) Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design. J Pharm Sci 85:491–495
Sammeta SM, Vaka SR, Murthy SN (2009) Transdermal drug delivery enhanced by low voltage electropulsation (LVE). Pharm Dev Technol 14:159–164
Sammeta SM, Vaka SR, Murthy SN (2010) Transcutaneous electroporation mediated delivery of doxepin– HPCD complex: A sustained release approach for treatment of postherpetic neuralgia. J Control Release 142:361–367
Sen A, Daly ME, Hui SW (2002a) Transdermal insulin delivery using lipid enhanced electroporation. Biochim Biophys Acta 1564:5–8
Sen A, Zhao YL, Hui SW (2002b) Saturated anionic phospholipids enhance transdermal transport by electroporation. Biophys J 83:2064–2073
Sharma A, Kara M, Smith FR, Krishnan TR (2000) Transdermal drug delivery using electroporation. I. Factors influencing in vitro delivery of terazosin hydrochloride in hairless rats. J Pharm Sci 89:528–535
Silva CL, Nunes SC, Eusébio ME, Sousa JJ, Pais AA (2006) Study of human stratum corneum and extracted lipids by thermomicroscopy and DSC. Chem Phys Lipids 140:36–47
Singh S, Singh J (1993) Transdermal drug delivery by passive diffusion and iontophoresis: a review. Med Res Rev 13:569–621
Singh J, Maibach HI (2002) Transdermal delivery and cutaneous reactions. In: Walters KA (ed) Dermatological and transdermal formulations. Marcel Dekker, New York, pp 529–547
Spirito F, Meneguzzi G, Danos O, Mezzina M (2001) Cutaneous gene transfer and therapy: the present and the future. J Gene Med 3:21–31
Sugino M, Todo H, Sugibayashi K (2009) Skin permeation and transdermal delivery systems of drugs: history to overcome barrier function in the stratum corneum. Yakugaku Zasshi 129(12):1453–1458
Sung KC, Fang JY, Wang JJ, Hu OY (2003) Transdermal delivery of nalbuphine and its prodrugs by electroporation. Eur J Pharm Sci 18:63–70
Takahashi M, Furukawa T, Saitoh H, Aoki A, Koike T, Moriyama Y et al (1991) Gene transfer into human leukemia cell lines by electroporation: experience with exponentially decaying and square wave pulse. Leuk Res 15:507–513
Teissie J, Rols MP (1993) An experimental evaluation of the critical potential difference inducing cell membrane electropermeabilization. Biophys J 65:409–413
Tekle E, Astumian RD, Chock PB (1994) Selective and asymmetric molecular transport across electroporated cell membranes. Proc Natl Acad Sci U S A 91:11512–11516
Tien HT, Ottova A (2003) The bilayer lipid membrane (BLM) under electrical fields. IEEE Trans Dielectr Electr Insul 10:717–727
Tobin DJ (2006) Biochemistry of human skin – our brain on the outside. Chem Soc Rev 35:52–67
Tokudome Y, Sugibayashi K (2003) The synergic effects of various electrolytes and electroporation on the in vitro skin permeation of calcein. J Control Release 92:93–101
Tokudome Y, Sugibayashi K (2004) Mechanism of the synergic effects of calcium chloride and electroporation on the in vitro enhanced skin permeation of drugs. J Control Release 95:267–274
Tokumoto S, Higo N, Sugibayashi K (2006) Effect of electroporation and pH on the iontophoretic transdermal delivery of human insulin. Int J Pharm 326:13–19
Tyle P (1986) Iontophoretic devices for drug delivery. Pharm Res 3:318–326
Vanbever R, Lecouturier N, Préat V (1994) Transdermal delivery of metoprolol by electroporation. Pharm Res 11:1657–1662
Vanbever R, LeBoulengé E, Préat V (1996) Transdermal delivery of fentanyl by electroporation I. Influence of electrical factors. Pharm Res 13:559–565
Vanbever R, Prausnitz MR, Préat V (1997) Macromolecules as novel transdermal transport enhancers for skin electroporation. Pharm Res 14:638–644
Vanbever R, Fouchard D, Jadoul A, De Morre N, Préat V, Marty JP (1998a) In vivo noinvasive evaluation of hairless rat skin after high-voltage pulse exposure. Skin Pharmacol Appl Skin Physiol 11:23–34
Vanbever R, Leroy MA, Préat V (1998b) Transdermal permeation of neutral molecules by skin electroporation. J Control Release 54:243–250
Vaughan TE, Weaver JC (2000) Mechanism of transdermal drug delivery by electroporation. In: Jaroszeski MJ, Heller R, Gilbert R (eds) Electrochemotherapy, electrogenetherapy and transdermal drug delivery. Humana Press, Totowa, pp 187–211
Wang S, Kara M, Krishnan TR (1998) Transdermal delivery of cyclosporin-A using electroporation. J Control Release 50:61–70
Wang RJ, Huang YB, Wu PC, Fang JY, Tsai YH (2007) The effects of iontophoresis and electroporation on transdermal delivery of indomethacin evaluated in vitro and in vivo. J Food Drug Anal 15:126–132
Weaver JC (1995) Electroporation theory. Concepts and mechanisms. Methods Mol Biol 47:1–26
Weaver JC, Vanbever R, Vaughan TE, Prausnitz MR (1997) Heparin alters transdermal transport associated with electroporation. Biochem Biophys Res Commun 234:637–640
Weaver JC, Vaughan TE, Chizmadzhev Y (1998) Theory of skin electroporation: implications of straight-through aqueous pathway segments that connect adjacent corneocytes. J Investig Dermatol Symp Proc 3:143–147
Weaver JC, Vaughan TE, Chizmadzhev Y (1999) Theory of electrical creation of aqueous pathways across skin transport barriers. Adv Drug Deliv Rev 35:21–39
Wells JM, Li LH, Sen A, Jahreis GP, Hui SW (2000) Electroporation enhanced gene delivery in mammary tumors. Gene Ther 7:541–547
Wong TW, Chen CH, Huang CC, Lin CD, Hui SW (2006) Painless electroporation with a new needle-free microelectrode array to enhance transdermal drug delivery. J Control Release 110:557–565
Yarmush ML, Golberg A, Serša G, Kotnik T, Miklavčič D (2014) Electroporation-based technologies for medicine: principles, applications, and challenges. Annu Rev Biomed Eng 16:295–320
Young JL, Dean DA (2015) Electroporation-mediated gene delivery. Adv Genet 89:49–88
Zhang L, Nolan E, Kreitschitz S, Rabussay DP (2002) Enhanced delivery of naked DNA to the skin by non-invasive in vivo electroporation. Biochim Biophys Acta 1572:1–9
Zorec B, Becker S, Reberšek M, Miklavčič D, Pavšelj N (2013) Skin electroporation for transdermal drug delivery: the influence of the order of different square wave electric pulses. Int J Pharm 457(1):214–223
Zorec B, Jelenc J, Miklavčič D, Pavšelj N (2015) Ultrasound and electric pulses for transdermal drug delivery enhancement: ex vivo assessment of methods with in vivo oriented experimental protocols. Int J Pharm 490(1–2):65–73
Acknowledgments
We acknowledge the financial support from Fraternal Order of Eagles and NSF EPSCoR (Grant No. EPS-0814442) doctoral fellowship to Buddhadev Layek.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Medi, B.M., Layek, B., Singh, J. (2017). Electroporation for Dermal and Transdermal Drug Delivery. In: Dragicevic, N., I. Maibach, H. (eds) Percutaneous Penetration Enhancers Physical Methods in Penetration Enhancement. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-53273-7_7
Download citation
DOI: https://doi.org/10.1007/978-3-662-53273-7_7
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-53271-3
Online ISBN: 978-3-662-53273-7
eBook Packages: MedicineMedicine (R0)